United Therapeutics UTHR Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $781.5M-1.1% | $790.2M-1.2% | $799.5M+0.1% | $798.6M+0.5% | $794.4M+7.9% | ||
| $133.4M+29.0% | $103.4M+2.5% | $100.9M+15.2% | $87.6M-5.3% | $92.5M+21.9% | ||
| $648.1M-5.6% | $686.8M-1.7% | $698.6M-1.7% | $711M+1.3% | $701.9M+6.3% | ||
| 82.9%-4.0pp | 86.9%-0.5pp | 87.4%-1.7pp | 89%+0.7pp | 88.4%-1.3pp | ||
| $138.2M-0.9% | $139.5M+9.4% | $127.5M-4.9% | $134M-10.1% | $149M+11.4% | ||
| $184.1M-3.4% | $190.6M+4.4% | $182.6M-14.1% | $212.5M+24.9% | $170.1M+0.9% | ||
| $455.7M+5.1% | $433.5M+5.5% | $411M-5.3% | $434.1M+5.5% | $411.6M+8.8% | ||
| $325.8M-8.7% | $356.7M-8.2% | $388.5M+6.6% | $364.5M-4.8% | $382.8M+7.0% | ||
| 41.7%-3.5pp | 45.1%-3.5pp | 48.6%+3.0pp | 45.6%-2.5pp | 48.2%-0.4pp | ||
| $3M-3.2% | $3.1M+3.3% | $3M-58.9% | $7.3M+19.7% | $6.1M-22.8% | ||
| -$7.5M-109% | $87.3M+76.4% | $49.5M+12.8% | $43.9M+7.9% | $40.7M+4.9% | ||
| $318.3M-28.3% | $444M+1.4% | $438M+7.2% | $408.4M-3.6% | $423.5M+6.8% | ||
| $43.4M-45.5% | $79.7M-19.7% | $99.3M+0.4% | $98.9M-2.4% | $101.3M+6.4% | ||
| $274.9M-24.5% | $364.3M+7.6% | $338.7M+9.4% | $309.5M-3.9% | $322.2M+6.9% | ||
| 35.2%-10.9pp | 46.1%+3.7pp | 42.4%+3.6pp | 38.8%-1.8pp | 40.6%-0.4pp | ||
| $5.82-24.3% | $7.69+7.4% | $7.16+11.7% | $6.41-3.3% | $6.63+6.8% | ||
| $348.4M-8.2% | $379.5M-7.5% | $410.4M+6.4% | $385.6M-4.2% | $402.6M+6.7% | ||
| 44.6%-3.4pp | 48%-3.3pp | 51.3%+3.0pp | 48.3%-2.4pp | 50.7%-0.6pp | ||
| $325.8M-8.7% | $356.7M-8.2% | $388.5M+6.6% | $364.5M-4.8% | $382.8M+7.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is United Therapeutics's revenue?
- United Therapeutics (UTHR) generated $3.2B in revenue over the trailing twelve months, up 5.9% year over year.
- Is United Therapeutics profitable?
- United Therapeutics reported $1.3B in net income over the trailing twelve months, a 40.6% net margin.
- What are United Therapeutics's profit margins?
- Gross margin is 86.6% and operating margin is 45.3%, with a 40.6% net margin.
- What is United Therapeutics's earnings per share?
- United Therapeutics's diluted EPS over the trailing twelve months is $27.08.
- Where does United Therapeutics's income statement data come from?
- Every line is extracted from United Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
